Lonza is a pioneer and world leader in the CDMO industry, founded in Switzerland in 1897. The company provides integrated development and manufacturing services across biologics, small molecules, cell and gene therapy, mRNA, and bioconjugates (ADCs/HPAPIs). With over 20,000 employees across five continents, Lonza serves the global pharmaceutical, biotech, and nutrition industries with end-to-end capabilities from early development to commercial-scale manufacturing.
integrated biologics development and manufacturing, mammalian cell culture, small molecule and HPAPI synthesis, cell and gene therapy manufacturing, mRNA manufacturing, ADC bioconjugation, viral vector production
7 sites worldwide
No reviews available yet.
No documents available.